| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Total Income - EUR | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Total Expenses - EUR | 1.763 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Gross Profit/Loss - EUR | -1.763 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Net Profit/Loss - EUR | -1.763 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Employees | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Dalia Abdulah Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 136.285 | 134.895 | - | 0 | 127.657 | 0 | 0 | 122.840 | 122.467 | - |
| Current Assets | 52 | 51 | - | 0 | 48 | 0 | 0 | 47 | 46 | - |
| Inventories | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Cash | 52 | 51 | - | 0 | 48 | 0 | 0 | 47 | 46 | - |
| Shareholders Funds | -11.589 | -11.470 | - | 0 | -10.855 | 0 | 0 | -10.445 | -10.414 | - |
| Social Capital | 45 | 45 | - | 0 | 42 | 0 | 0 | 41 | 40 | - |
| Debts | 147.925 | 146.416 | - | 0 | 138.561 | 0 | 0 | 133.332 | 132.928 | - |
| Income in Advance | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Dalia Abdulah Medical Srl